Skip to content

Maximus System

by Hill-Rom Services Pte. Ltd. 2 variants

510(k) K192143

Maximus System is a medical device (FDA Class II; FDA product code NHJ, Device, Positive Pressure Breathing, Intermittent) made by Hill-Rom Services Pte. Ltd., cleared under FDA 510(k) K192143 on 14 Feb 2020, active as of 22 Oct 2026. 7 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

7 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK192143 Date14 Feb 2020ClearedStatusActive

Official records

From the FDA record

Received by the FDA
8 Aug 2019
FDA decision
14 Feb 2020 (Substantially Equivalent)
FDA review time
190 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K192143 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

7 recalls · 7 ongoing · FDA

  • 4 recalls, same reason

    • Ongoing Z-2551-2026 FDA Class I initiated 21 May 2026
    • Ongoing Z-2549-2026 FDA Class I initiated 21 May 2026
    • Ongoing Z-2550-2026 FDA Class I initiated 21 May 2026
    • Ongoing Z-2548-2026 FDA Class I initiated 21 May 2026

    There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the patient and ineffective nebulization, which may affect the delivery of the prescribed treatment. The issue has been associated with improper locking of the nebulizer cup after adding medication during user setup.

    • Ongoing Z-1637-2026 FDA Class I initiated 18 Feb 2026

    Urgent Medical Device Correction for the Volara system single-patient use circuit due to the potential that patients or caregivers may be unaware of a possible decrease in oxygen levels (oxygen desaturation), or potential lung tissue injury from overexpansion (barotrauma) when the Volara device is used in the home care environment. This correction is providing the home caregiver specific instructions for use.

  • 2 recalls, same reason

    • Ongoing Z-2321-2024 FDA Class I initiated 30 May 2024
    • Ongoing Z-2322-2024 FDA Class I initiated 30 May 2024

    Potential of the handset plug to disconnect from the nebulizer port on the blue ventilator adapter. The handset plug is required to ensure proper operation and ventilator gas flow.

Timeline

8 dated events

  1. Cleared FDA 510(k) K192143
  2. Recall initiated FDA recalls Z-2321-2024
  3. Recall initiated FDA recalls Z-2322-2024
  4. Recall initiated FDA recalls Z-1637-2026
  5. Recall initiated FDA recalls Z-2551-2026
  6. Recall initiated FDA recalls Z-2549-2026
  7. Recall initiated FDA recalls Z-2550-2026
  8. Recall initiated FDA recalls Z-2548-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
NHJ
FDA applicant
Hill-Rom Services Pte, Ltd.
Device class
Class II
Regulation
21 CFR Part 868.5905
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code NHJ (Device, Positive Pressure Breathing, Intermittent).

Other devices from Hill-Rom Services Pte. Ltd.

See all devices from Hill-Rom Services Pte. Ltd. →